In gastric cancer and endometrial cancer, knockdown of Mettl14 and decreased m6A levels increased cell migration and invasiveness, establishing METTL14 as a negative regulator of migration and metastasis in these contexts (Liu et al., 2018; Zhang C. et al., 2019). This evidence concerns the gene METTL14 and endometrial cancer.